EQL Pharma

During the day EQL Pharma's CEO Axel Schörling, Chief Commercial Officer Alexander Brising and Chief Business Development Officer Carl Lindgren will give an updated investor presentation. The presentations will be held in English.

During the presentation, EQL will share its new long term financial targets and strategic plan with a special focus on how the company plans to reach these new targets. Additionally, the Business Development, Sales and M&A approaches will be covered in more detail as well as the key strategic assets Mellozzan and Memprex.

The event will be held at Carnegie's premises in Stockholm, Sweden and a live webcast will be available for those who cannot attend in person.

Location: Regeringsgatan 56, 111 56 Stockholm
Date & Time: 7 March 2025, 09:00-12:00 CET

Registration: https://tinyurl.com/bddzbxnh

It will be possible to ask questions both from the audience and via webcast during the presentations.

For inquiries regarding one-on-one meetings or other event-related questions, kindly send an email to ellen.mioen@carnegie.se.